Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Confluent (CFLT) Other Non Operating Income: 2020-2025

Historic Other Non Operating Income for Confluent (CFLT) over the last 6 years, with Sep 2025 value amounting to $18.4 million.

  • Confluent's Other Non Operating Income fell 18.38% to $18.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.2 million, marking a year-over-year decrease of 8.97%. This contributed to the annual value of $84.5 million for FY2024, which is 17.18% up from last year.
  • As of Q3 2025, Confluent's Other Non Operating Income stood at $18.4 million, which was down 13.02% from $21.1 million recorded in Q2 2025.
  • Over the past 5 years, Confluent's Other Non Operating Income peaked at $22.5 million during Q3 2024, and registered a low of -$816,000 during Q1 2022.
  • Moreover, its 3-year median value for Other Non Operating Income was $20.4 million (2025), whereas its average is $19.7 million.
  • As far as peak fluctuations go, Confluent's Other Non Operating Income slumped by 246.41% in 2021, and later spiked by 1,960.91% in 2023.
  • Confluent's Other Non Operating Income (Quarterly) stood at $1.5 million in 2021, then surged by 654.13% to $11.3 million in 2022, then soared by 92.24% to $21.8 million in 2023, then dropped by 11.42% to $19.3 million in 2024, then declined by 18.38% to $18.4 million in 2025.
  • Its Other Non Operating Income was $18.4 million in Q3 2025, compared to $21.1 million in Q2 2025 and $20.4 million in Q1 2025.